Treatment Approach, Pharmacological Agents and Vaccines
Authors:
- Quinton J. TafoyaQTQuinton J. Tafoya
- Victoria WatsonVWVictoria Watson
- Jacob PawloskiJPJacob Pawloski
- Ghada A. MohamedGMGhada A. Mohamed
- Ahmad Riad RamadanARAhmad Riad Ramadan
- 1 January 2021
- book chapter
- Published by Elsevier
- p. 145-162
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- The Neuropsychiatric Complications of Glucocorticoid Use: Steroid Psychosis RevisitedPsychosomatics, 2012
- Treatment of Myasthenia Gravis Based on Its ImmunopathogenesisJournal of Clinical Neurology, 2011
- Tracking parental attitudes on vaccination across European countries: The Vaccine Safety, Attitudes, Training and Communication Project (VACSATC)Vaccine, 2010
- New Insights on Adenovirus as Vaccine VectorsMolecular Therapy, 2009
- Factors associated with suboptimal compliance to vaccinations in children in developed countries: a systematic reviewCurrent Medical Research and Opinion, 2008
- Gene-based vaccines: recent technical and clinical advancesTrends in Molecular Medicine, 2006
- Vaccine Safety Controversies and the Future of Vaccination ProgramsThe Pediatric Infectious Disease Journal, 2005
- Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunityNature, 2002
- Direct Gene Transfer into Mouse Muscle in VivoScience, 1990
- Antibody response to pneumococcal polysaccharide vaccine in Myasthenia gravis: Effect of therapeutic plasmapheresisJournal of Clinical Apheresis, 1990